Skip to main content

Published locations for ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR

User login

Username

Password

Reset your password

/content/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/clinicianreviews/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/familypracticenews/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based
/fedprac/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/internalmedicinenews/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based
/clinicalendocrinologynews/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race
/ecardiologynews/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/cardiology/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/endocrinology/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/internalmedicine/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/familymedicine/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based-egfr
/type-2-diabetes-icymi/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based
/breast-cancer-icymi/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based
/b-cell-lymphoma-icymi/article/255311/diabetes/ada-updates-finerenone-sglt2-inhibitors-and-race-based